Monoclonal Gammopathy of Undetermined Significance (MGUS) Overview
Learn About Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Monoclonal gammopathy of undetermined significance
- MGUS
Baptist Health Services
Varant Arzoumanian is a Hematologist Oncology specialist and a Hematologist in Fort Smith, Arkansas. Dr. Arzoumanian and is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Arzoumanian is currently accepting new patients.
Baptist Health Regional Hospitals
Jeffrey Medlock is a Family Medicine provider in Alma, Arkansas. Dr. Medlock and is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Thrombocytopenia. Dr. Medlock is currently accepting new patients.
Baptist Health Services
Charles Jennings is a Geriatrics specialist and an Internal Medicine provider in Fort Smith, Arkansas. Dr. Jennings has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, Hip Replacement, and Bone Marrow Aspiration. Dr. Jennings is currently accepting new patients.
Summary: The primary purpose of the study is to understand how well the study drug can eliminate abnormal plasma cells and laboratory signs of high-risk monoclonal gammopathy of undetermined significance (HR-MGUS) and non high-risk smoldering multiple myeloma (NHR-SMM). This requires understanding the safety and tolerability of the study drug (how the body reacts to linvoseltamab) as well as the effectiven...
Summary: The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substa...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center